Mycobacterial Brain Tuberculomas due to Bacille Calmette-Guérin Intravesical Chemotherapy for Bladder Cancer: A Case Report and Literature Review
Bacille Calmette-Guérin (BCG) immunotherapy is widely used for the treatment of superficial bladder cancer. The authors believe that the present report is one of the first to document cerebral BCG tuberculoma in a 73-year-old immunocompetent man, three years after intra-vesical BCG immunotherapy. Hi...
Saved in:
Main Authors: | Vitaly Golub, Prashant Malhotra, Shital Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2011/869286 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bacille Calmette-Guérin Vaccination and Tuberculosis
by: Nick R Anthonisen
Published: (2005-01-01) -
The Use of Bacille Calmette-Guérin vaccination in Children
by: David P Speert
Published: (1995-01-01) -
Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
by: Masashi Miyazaki, et al.
Published: (2016-01-01) -
Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG)
by: Eric Gomez, et al.
Published: (2009-01-01) -
BAFF and APRIL immunotherapy following Bacille Calmette-Guérin vaccination enhances protection against pulmonary tuberculosis in mice
by: Min Xie, et al.
Published: (2025-02-01)